Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (584)	8/10/2001 12:33:23 PM
From: tuck	Read Replies (1) \| Respond to of 2243

Rick, >>If it wasn't MOGN, what is your single best idea? Please keep in mind that T/FIF focuses on high-risk and extreme leverage.<< Had to think about that for a few days. And prices changed in the meantime. MOGN was a good choice; I sold some puts. I like ABGX & ARNA now, and also NPSP. The latter was my choice at the time you asked this, and it is now no worse than tied with the former two as my "single" best idea. NPSP has pretty good leverage from the structure of its deals, IMO. Or at least flexibility. Oh yeah, then there's ONYX. That's now cheap, high risk, and high leverage. But I haven't done my research on it. Even if you choose not to get any of those, I'd be interested in your selection/rejection rationale. Cheers, Tuck